Therapy termination and apnoea-hypopnoea index (AHI)/central apnoea index (CAI) trajectories during continuous positive airway pressure (CPAP) therapy

H. Woehrle (Blaubeuren, Germany)

Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Session: Efficacy of and compliance with obstructive sleep apnoea treatment
Session type: Thematic Poster
Number: 2283
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Woehrle (Blaubeuren, Germany). Therapy termination and apnoea-hypopnoea index (AHI)/central apnoea index (CAI) trajectories during continuous positive airway pressure (CPAP) therapy. 2283

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of auto-titrating CPAP derived apnoea-hypopnoea index (AHI) with pulse oximeter oxygen desaturation index (ODI) in patients with obstructive sleep apnoea (OSA)
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016


Impact of continuous or automatic positive airway pressure (CPAP/ APAP) pressure change on the apnoea-hypopnoea index (AHI): big data analysis
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019

Continuous positive airway pressure in patients with obstructive sleep apnea: Adherence dependent on apnea-hypopnea index, leakage and mask pressure
Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea
Year: 2011


Impact of a custom-made mandibular repositioning device (MRD) on blood pressure (BP) in obstructive sleep apnea (OSA) patients noncompliant with continuous positive airway pressure (CPAP)
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015


Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012


The effect of volume targeted pressure support (PS) ventilation with autotitrating expiratory positive airways pressure (EPAP) and back up rate (BUR) on sleep quality in COPD-obstructive sleep apnoea (OSA) overlap syndrome
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013

Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

Factors influencing the level of efficient pressure of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSAS)
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Fixed-pressure CPAP versus auto-adjusting CPAP : Comparison of efficacy in obstructive sleep apnoea (OSAS) according to the individual level of efficient pressure and pressure variability.
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018



Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Effect of continuous positive airway pressure (CPAP) and pressure relief CPAP (C-flex) on neural drive in obstructive sleep apnoea
Source: Eur Respir J 2007; 30: Suppl. 51, 472s
Year: 2007

Pressure reduction during exhalation in sleep apnea patients treated by continuous positive airway pressure (CPAP)
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008


The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Obstructive sleep apnea syndrome and left ventricular diastolic function: effects of nasal continuous positive airway pressure (CPAP)
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006


Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS)
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010


Anthropometric and polysomnographic indices that influence optimal continuous positive airway pressure (CPAP) in sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Influence of nasal mask choice for continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnoea (OSA)
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014